glp 1 and muscle mass loss Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? GLP-1 medications don't just shrink
Description
Imbernon M, Saponaro C, Helms HCC, Duquenne M, Fernandois D, Deligia E, et al
Which is available in the UK first
What is a GLP-1 medication
For instance, insulin doses may need to be reduced by 10 to 20 percent, depending on baseline control and risk factors
That's why I like Pfizer as a possible GLP-1 play: it has some exciting upside but may not have nearly as much downside risk as other, smaller stocks.
Microdosing works the same way, but at a dose personalized for you, allowing your body to experience the benefits while minimizing potential side effects
